The most important financial indicators for the company Bristol-Myers Squibb Romania S.r.l. - Unique Identification Number 39157419:
sales in 2023 was
108.363.606
euro, registering a net profit of
3.358.132
euro and having an average number of
3
employees.
Firma isi desfasoara activitatea in domeniul Comert cu ridicata al produselor farmaceutice having the NACE code 4646.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales decreased by -8.3%, from 118.592.798 euro in the year 2022, to 108.363.606 euro in 2023.
The Net Profit decreased by -420.679 euro, from 3.790.304 euro in 2022, to 3.358.132 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Bristol-Myers Squibb Romania S.r.l. - CUI 39157419
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
-
-
-
-
0
0
0
726
437
145
Current Assets
-
-
-
-
15.689
97.085.718
96.979.820
101.527.417
104.636.916
97.458.136
Inventories
-
-
-
-
0
19.111.950
23.023.893
29.674.840
31.412.338
28.693.386
Receivables
-
-
-
-
0
74.065.716
68.895.670
64.366.830
70.287.188
59.641.790
Cash
-
-
-
-
15.689
3.908.052
5.060.257
7.485.747
2.937.390
9.122.960
Shareholders Funds
-
-
-
-
-76.983
1.826.346
4.504.130
40.541.087
44.457.170
47.680.488
Social Capital
-
-
-
-
817
801
786
32.344.910
32.445.260
32.346.872
Debts
-
-
-
-
92.673
95.259.372
92.486.612
61.011.846
60.191.215
49.793.431
Income in Advance
-
-
-
-
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"4646 - 4646"
CAEN Financial Year
4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
97.458.136 euro in 2023 which includes Inventories of
28.693.386 euro, Receivables of
59.641.790 euro and cash availability of
9.122.960 euro.
The company's Equity was valued at
47.680.488 euro, while total Liabilities amounted to
49.793.431 euro.
Equity increased by 3.358.132 euro, from 44.457.170 euro in 2022, to 47.680.488 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Bristol-Myers Squibb Romania S.r.l.